Keros Therapeutics commences tender offer to repurchase up to $194.4 million shares

3 hours ago 1

Keros Therapeutics (NASDAQ:KROS) has commenced a cash tender offer to repurchase up to $194.4 million of common shares, at a purchase price of $17.75 per share. The Company expects to fund the tender offer from its existing cash and cash equivalents.